Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow; S. G. Schwab; O. Rio; J. Mukherjee; R. Bjerkvig; T. A. Johannessen

doi:10.1093/neuonc/noab180.195

Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

K. Sarnow, S. G. Schwab, O. Rio, J. Mukherjee, R. Bjerkvig, T. A. Johannessen

Department of Cancer Research

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	56-56
DOIs	https://doi.org/10.1093/neuonc/noab180.195
Publication status	Published - Sept 2021
Event	16th Meeting of the European Association of Neuroncology (EANO) Virtual congress - Duration: 25 Sept 2021 → 26 Sept 2021

Conference

Conference	16th Meeting of the European Association of Neuroncology (EANO) Virtual congress
Period	25/09/21 → 26/09/21

Access to Document

10.1093/neuonc/noab180.195

Cite this

Sarnow, K., Schwab, S. G., Rio, O., Mukherjee, J., Bjerkvig, R., & Johannessen, T. A. (2021). Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression. 56-56. Abstract from 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress. https://doi.org/10.1093/neuonc/noab180.195

@conference{71c84355ea7e4896a694c5681d796077,

title = "Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression",

author = "K. Sarnow and Schwab, {S. G.} and O. Rio and J. Mukherjee and R. Bjerkvig and Johannessen, {T. A.}",

note = "Neuro-Oncology Volume: 23 Issue number: Suppl.2 Pages (from-to): 56-56 Article number: P15.02 ; 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress ; Conference date: 25-09-2021 Through 26-09-2021",

year = "2021",

month = sep,

doi = "10.1093/neuonc/noab180.195",

language = "English",

pages = "56--56",

}

Sarnow, K, Schwab, SG, Rio, O, Mukherjee, J, Bjerkvig, R & Johannessen, TA 2021, 'Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression', 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress, 25/09/21 - 26/09/21 pp. 56-56. https://doi.org/10.1093/neuonc/noab180.195

Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression. / Sarnow, K.; Schwab, S. G.; Rio, O. et al.

2021. 56-56 Abstract from 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Loss of williams syndrome transcription factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression

AU - Sarnow, K.

AU - Schwab, S. G.

AU - Rio, O.

AU - Mukherjee, J.

AU - Bjerkvig, R.

AU - Johannessen, T. A.

N1 - Neuro-Oncology Volume: 23 Issue number: Suppl.2 Pages (from-to): 56-56 Article number: P15.02

PY - 2021/9

Y1 - 2021/9

U2 - 10.1093/neuonc/noab180.195

DO - 10.1093/neuonc/noab180.195

M3 - Abstract

SP - 56

EP - 56

T2 - 16th Meeting of the European Association of Neuroncology (EANO) Virtual congress

Y2 - 25 September 2021 through 26 September 2021

ER -